Exicure, Inc. (XCUR) earnings

XCUR earnings moved a median of -0.35% by the close. Quarterly and annual XCUR reports and results, each read against the price at its own news timestamp. Back to the XCUR overview →

32 measured XCUR earnings events.

Where these XCUR earnings landedvs 32 measured XCUR earnings reactions
XCUR earningsMiddle 50% · -3.98% to +2.38%Zero: 0.00%Median: -0.35%Median -0.35%-5.00%0+5.00%
Middle 50% of XCUR earnings reactions-3.98% to +2.38%
Median reaction (to close)-0.35%
Measured reactions32
Point-in-time · zero look-ahead

Half of the 32 XCUR earnings events with a measured close landed between -3.98% and +2.38%; 44% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q EXICURE, INC. For: Jun 30SEC filing · Form 10-Q—-0.79%
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-QPress release-0.60%-6.61%
Form 10-Q EXICURE, INC. For: Mar 31SEC filing · Form 10-Q—+0.95%
Form NT 10-Q EXICURE, INC. For: Mar 31SEC filing · Form NT+0.00%+5.52%
Form 10-K EXICURE, INC. For: Dec 31SEC filing · Form 10-K—+1.99%
Exicure, Inc. Reports Third Quarter 2025 Financial ResultsPress release+0.00%-3.25%
Form 10-Q EXICURE, INC. For: Sep 30SEC filing · Form 10-Q+0.00%-3.25%
Exicure, Inc. Reports Second Quarter 2025 Financial ResultsPress release+0.07%+6.01%
Form 10-Q EXICURE, INC. For: Jun 30SEC filing · Form 10-Q+0.07%+6.01%
Exicure, Inc. Reports First Quarter 2025 Financial ResultsPress release+4.20%+9.49%
Form 10-Q EXICURE, INC. For: Mar 31SEC filing · Form 10-Q+4.20%+9.49%
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QPress release—+2.21%
Form NT 10-Q EXICURE, INC. For: May 15SEC filing · Form NT—-0.69%
Form 10-K EXICURE, INC. For: Dec 31SEC filing · Form 10-K+2.48%+6.61%
Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial ResultsPress release-5.06%-8.23%
Form 10-Q EXICURE, INC. For: Sep 30SEC filing · Form 10-Q-5.06%-8.23%
Exicure, Inc. Reports Second Quarter 2024 Financial ResultsPress release+0.15%-23.27%
Form 10-Q EXICURE, INC. For: Jun 30SEC filing · Form 10-Q+0.15%-23.27%
Exicure, Inc. Reports First Quarter 2024 Financial ResultsPress release+0.00%+2.07%
Form 10-Q EXICURE, INC. For: Mar 31SEC filing · Form 10-Q+0.00%+2.07%
Form 10-K EXICURE, INC. For: Dec 31SEC filing · Form 10-K-4.76%-5.69%
Form 10-Q/A EXICURE, INC. For: Jun 30SEC filing · Form 10-Q-4.76%-5.69%
Form 10-Q/A EXICURE, INC. For: Mar 31SEC filing · Form 10-Q-4.76%-5.69%
Exicure, Inc. Reports Third Quarter 2023 Financial ResultsPress release—-3.41%
Form 10-Q EXICURE, INC. For: Sep 30SEC filing · Form 10-Q—-3.41%
Form 10-Q/A EXICURE, INC. For: Jun 30SEC filing · Form 10-Q—-3.41%
Form 10-Q/A EXICURE, INC. For: Mar 31SEC filing · Form 10-Q—-3.41%
Form NT 10-Q EXICURE, INC. For: May 15SEC filing · Form NT—+5.27%
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KPress release+0.00%+2.91%
Form NT 10-K EXICURE, INC. For: Apr 01SEC filing · Form NT—+2.10%
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QPress release+0.21%+0.00%
Form NT 10-Q EXICURE, INC. For: Nov 14SEC filing · Form NT—+0.00%
That’s how XCUR usually reacts to earnings — get an email when it moves on news →
Keep exploring

More XCUR: analyst actions → · SEC filings → · XCUR overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
T2 Biosystems, Inc. (TTOO)174-0.92%40%
EARTH SCIENCE TECH INC (ETST)1730.00%33%
Aytu BioPharma, Inc. (AYTU)172-0.14%40%
Alpine Immune Sciences, Inc. (ALPN)171+0.05%54%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.